KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202 | +62.9% | 51,849 | +42.0% | 0.02% | +50.0% |
| Q4 2022 | $124 | -100.0% | 36,504 | -20.5% | 0.01% | -56.5% |
| Q3 2022 | $251,000 | +5.5% | 45,924 | -12.8% | 0.02% | +4.5% |
| Q2 2022 | $238,000 | -20.4% | 52,671 | +29.8% | 0.02% | +120.0% |
| Q1 2022 | $299,000 | +273.8% | 40,582 | +227.5% | 0.01% | +233.3% |
| Q4 2021 | $80,000 | -32.8% | 12,391 | -39.6% | 0.00% | -40.0% |
| Q3 2021 | $119,000 | +0.8% | 20,522 | +82.2% | 0.01% | -50.0% |
| Q1 2021 | $118,000 | – | 11,264 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |